Rxi Pharmaceuticals is extremely undervalued should approaching catalysts fulfill promise.

Mdtech analyst that has allowed the WBB Securities cofounder to develop a reasoned perspective on how West Africa's Ebola epidemic might be humanely halted. Brozak also mentions small-cap names that could considerably enhance investors' portfolios.

Even with human costs paramount, a global crisis has impact on investments.

Tekmira Pharmaceuticals (TKMR) and European drug developer Bavarian Nordic (BAVA.CO) are receiving significant attention in early trading on Wednesday morning with announcements that their two distinct approaches to Ebola, a therapeutic and vaccine respectively, are advancing.

Tekmira reports pre-clinical results on Hepatitis B drug

Alnylam posts positive phase 2 results in open-label study.